clinical trials

  1. H

    India’s Bioeconomy Surpasses $200 Billion, Signaling Growth

    New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
  2. K

    J P Nadda Urges Pharma Industry to Anchor Global Supply Chains with Quality and Innovation

    India Calls for Trust, Reliability and Innovation in Redesigned Global Pharma Supply Chains Mumbai, February 23: Union Minister J P Nadda on Monday called upon India’s domestic pharmaceutical industry to take a leadership role in the evolving global supply chain by focusing not only on scale but...
Back
Top